NVCR

NovoCure Limited Ordinary Shares
Data: 2026-01-30
$12.4
Price
0.48%
Change
$26.465
52W High
$10.7
52W Low

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Quick Stats
Jan 30, 2026

50.8

AI Score

HOLD

1.4

Volume Ratio

Feb 26, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

NVCR Stock Summary

Last updated Jan 30, 2026

NVCR is currently trading at $12.4, positioned below its 200-day moving average of $14.31, suggesting bearish momentum. The stock has a 52-week range of $10.7 to $26.465.

Technical Analysis: The 50-day moving average stands at $12.96, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.969, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.02, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates NVCR at 50.8/100 with a HOLD recommendation.

NVCR (NovoCure Limited Ordinary Shares) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 39.969
CMF (20) 0.02
ROC (10) -10.145
ADX (14) 17.529
Indicator Value
MACD (12,26,9) -0.132
AROONOSC (14) -100.0
WILLAMS %R (14) -94.265
MFI (14) 34.304
NVCR Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

NVCR Price vs Max Options Open Interest
NVCR Max Change In Options Open Interest

NVCR Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NVCR Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NVCR Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NVCR Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

NovoCure Limited Ordinary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

NVCR Moving Averages Analysis

NVCR (NovoCure Limited Ordinary Shares) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 13.16
20 13.59
30 13.42
50 12.96
100 12.97
200 14.31

NVCR Fundamental Analysis

P/E (Forward) 909.0909
P/E (Trailing) --
Market Cap ($) 1.4 billion
Earnings/Share ($) -1.61
Net Proft Margin (%) -0.2766
Dividend/Share ($) --
EPS Estimate Current Year ($) -1.3957
EPS Estimate Next Year ($) -1.4886
WallStreet Target Price ($) 24.0714
Most Recent Quarter